Company profile
Astex Oncology and CNS Drug Discovery & Development
Astex Therapeutics Limited is a UK company with status active founded in 1999 based in East of England.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Sep 2023 to 31 Aug 2025
OutSee Limited working with Astex Pharmaceuticals will be unlocking value and insights in non-coding genomic data through the _Nomaly_ approach to support precision medicine for dementia patients. We will be developing new AI to tackle the non-coding part of the genome alongside discovery developed on the protein-coding variation in the genome. Dementia i...
1 Nov 2021 to 30 Apr 2023
The process of discovering and testing new drugs is very expensive and takes a long time. The average cost of discovering a new drug and bringing it to market has tripled since 2010, reaching almost $3bn in 2018\. Current methods for discovering new drugs are unreliable and involve a 'trial-and-error' approach. Pharmaceutical companies want to reduce the ...
